Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:2481-2485
doi: 10.1161/hs1101.098329
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conway, J. E.
Right arrow Articles by Tamargo, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conway, J. E.
Right arrow Articles by Tamargo, R. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Aneurysm
*Genetics Home Reference
Related Collections
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Risk Factors for Stroke

(Stroke. 2001;32:2481.)
© 2001 American Heart Association, Inc.


Original Contributions

Lack of Evidence for an Association Between Neurofibromatosis Type I and Intracranial Aneurysms

Autopsy Study and Review of the Literature

James E. Conway, MD, PhD; Grover M. Hutchins, MD Rafael J. Tamargo, MD

From the Department of Neurosurgery (J.E.C., R.J.T.), Division of Cerebrovascular Neurosurgery, and the Department of Pathology (G.M.H.), Johns Hopkins Medical Institutions, Baltimore, Md.

Correspondence to Rafael J. Tamargo, MD, FACS, Associate Professor of Neurosurgery, Director, Division of Cerebrovascular Neurosurgery, Department of Neurosurgery, Johns Hopkins Hospital, Meyer 7-113, 600 N Wolfe St, Baltimore, MD 21287-7713. E-mail jconway{at}welchlink.welch.jhu.edu

Background and Purpose— Neurofibromatosis type I (NF1) is an autosomal dominant, hereditary, neurocutaneous syndrome purported to be associated with intracranial aneurysms. To study the relationship between NF1 and intracranial aneurysms, we have analyzed all intracranial autopsies of NF1 patients performed at our institution from 1889 to 1999 and analyzed all intracranial aneurysm cases at our institution from 1990 to 1999 in an attempt to identify patients with NF1. In addition, we have reviewed published clinical series of NF1 patients.

Methods— The autopsy database at our institution, which contains 50 000 cases from 1889 to 1999, was searched to identify NF1 patients, and the results of these autopsies were reviewed. The prevalence of intracranial aneurysms in these NF1 patients was compared with the prevalence of intracranial aneurysms in our hospital’s autopsy population and with the published prevalence of intracranial aneurysms in the general population. To identify patients with intracranial aneurysms and NF1, our institution’s intracranial aneurysm database was searched for patients with clinical manifestations of NF1. Published clinical series of NF1 patients were identified through searches of the literature.

Results— None of the 25 autopsy patients with NF1 had an intracranial aneurysm. None of the 925 patients treated for intracranial aneurysms were affected by NF1. A review of the literature identified 8 comprehensive clinical studies, all of which failed to document any relationship between NF1 and intracranial aneurysms.

Conclusions— The autopsy prevalence of no NF1 patients with intracranial aneurysms out of 25 is not different from the prevalence of intracranial aneurysms in the general autopsy population. In addition, no patients treated for intracranial aneurysms at this institution had NF1. These findings are supported by the observation that an association between NF1 and intracranial aneurysms has never been identified in 8 large clinical studies of NF1 patients. We conclude that there is a lack of evidence for any association between NF1 and intracranial aneurysms.


Key Words: aneurysm • autopsy • neurofibromatosis




This article has been cited by other articles:


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
K. T. Delis and P. Gloviczki
Neurofibromatosis Type 1: From Presentation and Diagnosis to Vascular and Endovascular Therapy
Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2006; 18(3): 226 - 237.
[Abstract] [PDF]